Cargando…
Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
Trypanosoma cruzi is the protozoan parasite that causes Chagas disease, which is considered by the World Health Organization to be a neglected tropical disease. Two drugs exist for the treatment of Chagas disease, nifurtimox and benznidazole; they are only effective in the acute phase, and a vaccine...
Autores principales: | Arce-Fonseca, Minerva, González-Vázquez, María Cristina, Rodríguez-Morales, Olivia, Graullera-Rivera, Verónica, Aranda-Fraustro, Alberto, Reyes, Pedro A., Carabarin-Lima, Alejandro, Rosales-Encina, José Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964559/ https://www.ncbi.nlm.nih.gov/pubmed/29854848 http://dx.doi.org/10.1155/2018/8964085 |
Ejemplares similares
-
Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach
por: Diaz-Hernandez, Alejandro, et al.
Publicado: (2022) -
DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi
por: Arce-Fonseca, Minerva, et al.
Publicado: (2020) -
Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2012) -
Effect of the Plasmid-DNA Vaccination on Macroscopic and Microscopic Damage Caused by the Experimental Chronic Trypanosoma cruzi Infection in the Canine Model
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2013) -
Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model
por: Arce-Fonseca, Minerva, et al.
Publicado: (2023)